Congress Wants More Answers From J&J On "Phantom Recall"
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's response to a congressional inquiry regarding the alleged "phantom recall" of a Motrin product left a House committee chairman considering whether to subpoena additional information